EyExam
AI-based Solution for the Diagnosis of Eye Diseases
Health Tech & Life Sciences
Non Active, Jun 2020 ceased to operate
Company Overview
Snapshot
Founded in July 2019 by Tamar Levi Vineberg, EyExam operated with 1–10 employees. The company ceased operations in June 2020.
Business overview
EyExam developed an AI-based solution for diagnosing and tracking eye diseases such as age-related macular degeneration and diabetic retinopathy. The company's technology analyzed optical coherence tomography (OCT) images to provide detailed diagnoses, including urgency of care, biomarkers, and recommended treatments. EyExam operated within the Health Tech & Life Sciences sector, specifically focusing on digital healthcare and digital medical diagnostics, serving the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is EyExam's primary focus?
- EyExam focuses on providing an accessible, affordable AI-based solution for diagnosing and tracking eye diseases like age-related macular degeneration and diabetic retinopathy.
- When was EyExam founded?
- EyExam was founded in July 2019.
- What technology does EyExam utilize?
- EyExam utilizes an AI-based solution to analyze optical coherence tomography (OCT) images for diagnosis.
- What kind of information does EyExam's solution provide?
- EyExam's solution delivers a detailed diagnosis, including urgency of care, biomarkers, and recommended treatment for eye diseases.
- What is the operational status of EyExam?
- EyExam ceased to operate in June 2020.